Multi-center, Randomized, Double-blind, Placebo/Active-controlled, Phase II Clinical Trial to Assess the Safety and Efficacy of YHD1023 in Patients With Erectile Dysfunction.

Trial Profile

Multi-center, Randomized, Double-blind, Placebo/Active-controlled, Phase II Clinical Trial to Assess the Safety and Efficacy of YHD1023 in Patients With Erectile Dysfunction.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Aug 2014

At a glance

  • Drugs YHD 1023 (Primary) ; Tadalafil
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors Yuhan
  • Most Recent Events

    • 30 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jun 2014 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0001049)
    • 13 May 2013 Planned end date changed from 1 May 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top